ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
18
views
0
references
Top references
cited by
8
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,613
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Rivastigmine in the treatment of Huntington's disease.
Author(s):
U Rot
,
Z Pirtosek
,
A Mesec
,
A Sever
,
J Kobal
Publication date:
2002-10-31
Journal:
European Journal of Neurology
Keywords:
Carbamates
,
therapeutic use
,
Cholinesterase Inhibitors
,
Humans
,
Huntington Disease
,
drug therapy
,
Phenylcarbamates
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
A Sustainable Future
Author and article information
Journal
PubMed ID::
12453090
DOI::
10.1046/j.1468-1331.2002.00447_4.x
ScienceOpen disciplines:
Chemistry
Keywords:
Carbamates
,
therapeutic use
,
Cholinesterase Inhibitors
,
Humans
,
Huntington Disease
,
drug therapy
,
Phenylcarbamates
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Carbamates
,
therapeutic use
,
Cholinesterase Inhibitors
,
Humans
,
Huntington Disease
,
drug therapy
,
Phenylcarbamates
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,613
Long-term efficacy of rivastigmine in the treatment of Alzheimer’s disease.
Authors:
H Haihua
,
L. Mingqiu
,
J Gaoxuan
…
Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine
Authors:
Constantin Kondak
,
Gernot Riedel
,
Charles R Harrington
…
Quality-by-design driven analytical method (AQbD) development and validation of HPLC–UV technique to quantify rivastigmine hydrogen tartrate in lipidic nanocarriers: Forced degradation, and assessment of drug content and in vitro release studies
Authors:
Salwa
,
L Kumar
See all similar
Cited by
8
New Avenues for the Treatment of Huntington’s Disease
Authors:
Amy Kim
,
Kathryn Lalonde
,
Aaron Truesdell
…
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Authors:
Raphael Bonelli
,
Anna H??dl
,
Peter. Hofmann
…
Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation
Authors:
Claudia Rangel-Barajas
,
George Rebec
See all cited by